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Purpose: To investigate the production of antibiotic from actinomycetes isolated from soil and evaluate 
its antimicrobial activities.   
Methods: In a medium formulation study, A-4 and A-4 actinomycete mutant strains (out of the six 
strains selected from the nine actinomycetes that were screened) were evaluated for maximum 
antibiotic production using various carbon and nitrogen sources. Zone of inhibition and packed cell 
volume were the parameters used for the evaluation. Various fermentation conditions such as pH, 
temperature and dissolved oxygen were also optimized for maximal production of antibiotic from both A-
4 and A-4 mutant.  
Results: Some actinomycetes strains showed promising antimicrobial activity against different strains of 
bacteria and fungi. Out of the six strains selected, one strain, designated A-4, showed maximum 
antimicrobial property against Gram positive and Gram negative strains as well as against various fungi.  
Conclusion: Findings from this investigation reveal that strain A-4 and A-4 mutant strains, in that order, 
exhibited superior antimicrobial activities to other soil isolates of actinomycetes.  
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INTRODUCTION 
 
The continuing success of a biotechnologist 
in the search for microbial metabolites for use 
as antimicrobial compounds (antibiotics) is 
critical to combating human, animal and plant 
diseases. Microorganisms constitute an 
inexhaustible reservoir of compounds with 
pharmacological, physiological, medical or 
agricultural applications [1-3]. Antibiotics 
continue to play a crucial role in the 
development of tissue culture techniques and 
basic screenings, primarily in biochemistry, 
molecular biology, microbiology and genetics 
(including genetic engineering) and to a 
lesser extent, pharmacology and organic 
chemistry.  
 
The actinomycetes are Gram positive, 
organisms that tend to grow slowly as 
branching filaments. Many actinomycetes will 
grow on the common bacteriological media 
used in the laboratory, such as nutrient agar, 
trypticase soy agar, blood agar, and even 
brain-heart infusion agar. Actinomycetes 
encompass a wide range of bacteria. They 
have universal occurrence and play an active 
part in the cycle of nature [4,5].
 
Antibiotics are 
the best known products of actinomycete. 
The morphology of an actinomycete growing 
on agar can provide useful and rapid clues to 
its identity, but viewing isolated colonies can 
give little worthwhile information. 
Morphological characters are still widely used 
for characterizing genera, for example, the 
presence or absence of spores on the 
substrate mycelium or the formation of 
zoospores in specialized spore vesicles or 
sporangia. The ability to produce motile 
spores is more widespread in the 
actinomycetes. [6]. 
The present study is an attempt to produce 
antibiotics from actinomycetes, isolated from 
soil, by fermentation and the determination of 





Dextrose IP, NaCl, soyabean meal, n-
butanol, silicon oil, dimethyl sulphoxide 
(DMSO), n-hexane, tryptone, lactose, 
maltose, fructose, yeast extract powder, 
nutrient agar, agar powder, International 
Streptomycetes Project (ISP) 2 to 7 media, 
actinomycetes agar, Bennett’s agar, nutrient 
broth, sucrose, silica gel 60-120 mesh, 
silicagel powder, chloroform, ethyl acetate, 
and starch were obtained from Nice 
Chemicals Ltd, Mumbai. Magnesium 
sulphate, potassium dihydrogen phosphate, 
methanol, silica gel (TLC grade), peptone 
(Loba Chemicals Ltd, Mumbai), skimmed milk 
and glucose were also used in this study. 
They were all of analytical/pharmacopoeial 
grade and used as received without further 
purification. 
 
Optimization of fermentation parameters 
 
The following fermentation parameters were 
found to be ideal for maximum antibiotic 
productivity using A-4 strain of actinomycete 
[10]: (a) temperature, 28 °C; (b) pH, 7.0 (c); 
dissolved oxygen (DO2) concentration, 60 %; 
(d) harvesting time (fermentation duration), 
96 h ; and (e) inoculum concentration, 10 
%v/v. 
 
Optimization of fermentation duration 
 
The duration of the fermentation process was 
optimized to obtain the harvesting time for 
maximum antibiotic productivity. Using the 
foregoing media formulation and fermentation 
parameters and conditions, the media were 
prepared and sterilized, inoculated with 10 % 
of a 24-h incubated inoculum of A-4 and then 
incubated for 0 to 144 h. The harvesting time 
for maximum antibiotic productivity was 
determined by packed cell volume (PCV) and 
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Downstream process for fermentation 
 
Fermentation was carried out for 4 days at 
the optimized fermentation parameters 
indicated above. Following fermentation, the 
medium was centrifuged at 10,000 rpm for 
half an hour at 4 °C to remove biomass and 
cell debris and the supernatant was 
separated. The cell pellet of the biomass was 
triturated with sterile sand to disrupt the cell 
wall, washed with Tris buffer (pH 7.4) filtered 
and centrifuged, and the supernatant, which 
contained all the intracellular components, 
was separated out. Both sets of supernatant 
were assessed for antimicrobial activity [12].  
 
Determination of antimicrobial activity  
 
Antimicrobial activity was determined by cup 
plate technique. The test bacteria were grown 
on nutrient agar while the test fungi were 
grown on Sabouraud dextrose agar. The 
extracts, i.e., supernatant liquid from 
fermentation media, were dissolved in 200 ml 
of ethyl acetate and 50 µL of the solution was 
placed in the agar cup. Growth inhibition was 
measured after incubation for 24 h at 37 
0
C 
for bacteria and 72 h at 27 
0
C for fungi. 
Antimicrobial activity was estimated by 
measuring the inhibition zone diameters 
[11,12].  
 
Structural identification of antimicrobial 
compound  
 
The structure of the isolated compound was 
characterized using nuclear magnetic 
resonance (NMR) spectroscopy [13].  
 




The optimization data for optimum growth 
and antibiotic production with regard to the 
maximum duration of fermentation are shown 
in Table 1. 
 
 
Table 1: Optimization data for duration of fermen-
tation for antibiotic production 
 





























































Well diameter = 0.9 cm; test organism = Klebsiella 
pneumoniae; PCV = packed cell volume 
    
 Antimicrobial activity 
 
Table 2 shows the minimum inhibitory 
concentration (MIC) of the isolated antibiotics 
from A-4 and A-4 mutant fermentation broth. 
The antibiotics showed broad spectrum of 
activity against Gram-positive and Gram-
negative organisms with MIC in the range of 
100 - 125 and 62.5 – 100 µg/ml, for A-4 and 
A-4 mutant respectively. The isolated 
compounds also showed significant 
antifungal activity against fungal strains with 
MIC of 125 and 62.5 -125 µg/ml for A-4 and 
A-4 mutant, respectively. 
   
Table 2: MIC of the isolated antibiotics against 
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Structure of antibiotic 
 
NMR spectroscopic data and the functional 
groups of the antibiotic are shown in Table 3.  
    
Table 3: NMR spectroscopic data for the isolated 
antibiotic 
  
δ value Functional group 
1.24 Methyl H-shift 
2.86 Methyl H-shift 
3.29 Aldehyde 
3.48 Alcohols  
3.7 Esters  





Medium formulation is necessary for each 
fermentation process. It is necessary to 
optimize each and every component of 
fermentation media by varying the 
concentration of media constituents in order 
to achieve maximum antibiotic production. 
The purpose of media optimization is to 
support efficient growth of microorganisms. 
Different combinations of medium 
constituents and sequences of optimized 
fermentation conditions need to be 
investigated to determine growth conditions 
that produce biomass that is physiologically 
best suited for antibiotic production. 
 
For fermentation process optimization, a 
basal medium containing 0.3 % yeast extract, 
0.35 % CaCO3 and 0.5 % NaCl was used for 
antibiotic production as indicated in the 
literature [10,12]. In order to achieve 
maximum antibiotic production, experiments 
were conducted to optimize the various 
parameters such as carbon source, nitrogen 
source, temperature, pH, DO2, and 
micronutrients etc. It was observed that rapid 
utilizable carbon source did not support the 
antibiotic production as antibiotic synthesis 
does not totally depend on the growth of the 
microorganism; rather, it depends upon the 
adverse conditions imposed by the medium 
or surroundings.  
The antibiotics isolated from A-4 and A-4 
mutant fermentation broth showed broad 
spectrum of activity against both Gram-
positive and Gram-negative organisms (MIC, 
100-125 µg/ml) a swell as antifungal activity 
(MIC, 62.5 - 125 µg/ml). They demonstrated 
superior antimicrobial activity to other soil 
isolates of actinomycetes that were 
investigated. The A-4 mutant showed higher 
antibiotic potency. NMR studies showed that 





The findings from this investigation reveal 
that the strains, A-4 and A-4 mutant, which 
were soil isolates of actinomycetes, exhibited 
superior antimicrobial activity to other soil 




1. Smith JE. Perspective in biotechnology and applied 
microbiology, Murray Moo-Young, 1989; pp 
105-134. 
2. Bulock J. Basic Biotechnology. Academic Press, 1987; 
pp 425-448. 
3. Vandemme EJ. Biotechnology of Industrial Antibiotics. 
Dekker Series, Vol. 22, Marcel Dekker Inc., 
New York, 1948; pp 3-42. 
4. Syker G and Skinner FA. Actinomycetes: 
Characteristics and practical importance. 
Academic Press, London & New York, 1973; 
pp 1-91 and 231-247.  
5. Edward G. Bergey’s J. Manual of Derminative 
Bacteriology. 9
th
 ed. WMC Brown Publishers, 
USA, 1974; pp 712-829. 
6. Brun YV, Skimkets LJ. Prokaryotic development. ASM 
Press, 2000; pp 11-31. 
7. Lebrihi A, Lamsaif D, Lefebure G, Germain P. Effect of 
ammonium ions on spiramycin    biosynthesis 
in Streptomyces ambofaciens, Appl. Microbiol 
Biotechnol 1992;  37:382- 387. 
8. Okada S, Iwamatu S. Scale-up production of 
milbemycin by Streptomyces hygroscopicus 
    subspecies aureolacrimosus with control of internal 
pressure, temperature. Aeration and   
Agitation, J Chem Technol Biotechnol 1997; 
70: 179-187. 
9. Jain PK, Jain PC. Production of heptaene antifungal 
antibiotic by Streptomyces purpeofuscus CM-
1261, Indian J Exp Biol. 2005;   43: 342-345. 
10. James PDA, Edwards C, Dawson M. The effects of 
temperature, pH and growth rate on secondary 
metabolism in Streptomyces thermoviolaceus 
Nanjwade et al 
Trop J Pharm Res, August 2010; 9 (4): 377 
grown in a  chemostat. J Gen Microbiol 1991; 
137: 1715-1720. 
11. Haque SKF, Sen SK, Pal SC. Antimicrobial spectra 
and toxicity of antibiotics    from      
Streptomyces antibioticus sr 15-4, Indian J. 
Microbiol 1996; 36: 113-114. 
12. Antal N, Fiedler HP, Stackebrandt E, Beil W. Novel 
secondary metabolites from      
Micromonospora sp.Tii 6368. Taxonomy, 
fermentation, isolation and biological      
activities, J Antibiot 2005; 58(2): 95-102. 
13. Gunther H. NMR Spectroscopy II edition, John Wiley 
and sons: New york 1986; 15-52. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
